🕵️ Aardvark Therapeutics, Inc. ($AARD)
SEC insider & ownership activity, last 12 months · CIK 1774857 · every row links its SEC filing
Over the last 12 months insiders sold $395K against $145K of open-market buying. Sun Nelson sold $395K through a 10b5-1 trading plan in 2 lots (Dec–Sep). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $145K (2 lots) · 1 seller, $395K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Sun Nelson | 1 | $43K | 2 | $395K | Sep 11, 2026 |
| Lee Tien-Li | 1 | $101K | 0 | – | Dec 11, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Xiangmin Cui | 18.3% | 13G | Feb 24, 2025 | filing ↗ | |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 13.8% | 13G | Feb 24, 2025 | filing ↗ | |
| Decheng Capital Management IV (CAYMAN), LLC | 13.8% | 13G | Feb 24, 2025 | filing ↗ | |
| Tien-Li Lee | 13.7% | 13G | May 15, 2025 | filing ↗ | |
| Jane Wu Lee | 13.7% | 13G | May 15, 2025 | filing ↗ | |
| Vickers Venture Fund VI PTE. Ltd. | 9.6% | 13G | Feb 24, 2025 | filing ↗ | |
| Dr. Finian Tan | 8.7% | 13G | Feb 24, 2025 | filing ↗ | |
| Christopher Michael Ho | 7.9% | 13G | Feb 24, 2025 | filing ↗ | |
| Kenneth Griffin | 5.6% | 13G | Feb 24, 2025 | filing ↗ | |
| Citadel Advisors LLC | 5.4% | 13G | Feb 24, 2025 | filing ↗ | |
| Citadel Advisors Holdings LP | 5.4% | 13G | Feb 24, 2025 | filing ↗ | |
| Citadel GP LLC | 5.4% | 13G | Feb 24, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Nelson Sun | $170K | Sep 11, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Aug 14, 2026 | filing ↗ |
| Earnings (2.02) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Earnings (2.02) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Other events (8.01) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Other events (8.01) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 9, 2026 | filing ↗ |
| Other events (8.01) | Feb 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing ↗ |
| Other events (8.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Other events (8.01) | Dec 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Other events (8.01) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 4, 2025 | filing ↗ |
| Other events (8.01) | Nov 4, 2025 | filing ↗ |